Page last updated: 2024-10-26

diphenyleneiodonium and Nasopharyngeal Carcinoma

diphenyleneiodonium has been researched along with Nasopharyngeal Carcinoma in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, J1
Hu, C1
Zhu, Y1
Sun, R1
Fang, Y1
Fan, Y1
Xu, F1

Other Studies

1 other study available for diphenyleneiodonium and Nasopharyngeal Carcinoma

ArticleYear
LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Carcinoma; Cell Line; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Enzyme Inhib

2015